Harbor Health Care ETF Rating $34.81 0.00 (0.00%) As of 07/2/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Harbor Health Care ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDI Aggregate RatingModerate Buy 2.84Holdings in MEDI have an aggregate rating of Moderate Buy based on 529 analyst ratings issued in the past year covering 25 companies (92.4% of the portfolio).MEDI Aggregate Price Target$34.81High Prediction$34.81Average Prediction$34.81Low Prediction$34.81Holdings in MEDI have an aggregate price target of $34.81 and a range of $34.81 to $34.81 covering 25 companies (92.4% of the portfolio).MEDI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Harbor Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 MEDI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings20.48%LLYEli Lilly and Company$1,208.37-0.5%4.2855 of 5 stars2.87$1,235.07 2.2%30Trending NewsAnalyst UpgradeAnalyst Revision16.79%ASNDAscendis Pharma A/S$274.504.1433 of 5 stars3.00$295.39 7.6%19Analyst Upgrade4.70%LEGNLegend Biotech$29.913.1123 of 5 stars2.67$60.23 101.4%154.41%RYTMRhythm Pharmaceuticals$114.172.3459 of 5 stars2.83$133.13 16.6%18Positive NewsGap Down4.29%GILDGilead Sciences$131.274.9705 of 5 stars2.86$158.41 20.7%29Positive NewsInsider TradeAnalyst RevisionGap Down3.26%ISRGIntuitive Surgical$426.014.3493 of 5 stars2.67$573.42 34.6%27Trending NewsAnalyst RevisionGap Down3.19%ABBVAbbVie$260.88-0.1%4.0114 of 5 stars2.88$253.81 -2.7%25Analyst DowngradeAnalyst RevisionGap Down2.99%INSMInsmed$111.603.6884 of 5 stars2.96$211.86 89.8%25Positive NewsGap Down2.77%NTRANatera$279.321.725 of 5 stars2.86$260.33 -6.8%222.76%ABVXAbivax$144.651.4161 of 5 stars2.81$146.00 0.9%16Trending NewsAnalyst Forecast2.62%RVMDRevolution Medicines$189.241.9097 of 5 stars3.00$135.39 -28.5%22News CoverageAnalyst ForecastInsider Trade2.53%BSXBoston Scientific$45.09-0.1%4.9911 of 5 stars2.80$83.36 84.9%30Positive NewsShort Interest DecreaseAnalyst RevisionGap Down2.31%MRKMerck & Co., Inc.$129.34-0.2%4.4681 of 5 stars2.70$131.83 1.9%20Positive NewsAnalyst ForecastAnalyst RevisionGap Down2.08%PCVXVaxcyte$58.392.2697 of 5 stars2.63$86.00 47.3%8Gap Down1.97%CORCencora$296.430.0%4.9218 of 5 stars2.73$367.75 24.1%15News CoveragePositive NewsAnalyst DowngradeGap Down1.84%ARGXargenex$939.683.6692 of 5 stars2.92$1,034.56 10.1%24Analyst Forecast1.76%GHGuardant Health$167.981.8458 of 5 stars2.96$147.32 -12.3%24Analyst ForecastInsider TradeGap Up1.73%VRTXVertex Pharmaceuticals$528.043.5736 of 5 stars2.84$555.91 5.3%25Analyst DowngradeInsider TradeGap Down1.73%UNHUnitedHealth Group$424.64-0.2%4.5987 of 5 stars2.81$411.42 -3.1%27Trending NewsAnalyst Forecast1.67%IDXXIDEXX Laboratories$557.803.5718 of 5 stars2.64$751.00 34.6%11Positive News1.41%PODDInsulet$164.484.5662 of 5 stars2.71$238.67 45.1%28Trending NewsGap Down1.41%PTCTPTC Therapeutics$83.313.0807 of 5 stars2.71$91.36 9.7%14Insider TradeGap DownHigh Trading Volume1.36%ADPTAdaptive Biotechnologies$21.192.5463 of 5 stars2.57$20.50 -3.3%7Insider TradeGap Up1.25%NVONovo Nordisk A/S$50.39-0.1%4.1942 of 5 stars2.17$65.56 30.1%23Trending NewsAnalyst Revision1.11%DHRDanaher$197.850.0%4.5298 of 5 stars2.80$233.61 18.1%25 This page (NYSEARCA:MEDI) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harbor Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Harbor Health Care ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
